{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:47:49Z","timestamp":1792133269184,"version":"4.4.0"},"reference-count":29,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"DOI":"10.61622\/rbgo\/2025rbgo77","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:27:48Z","timestamp":1763501268000},"source":"Crossref","is-referenced-by-count":4,"title":["Low adherence to aspirin and calcium carbonate for preeclampsia prevention in pregnant women with chronic hypertension in a brazilian hospital"],"prefix":"10.61622","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2464-3673","authenticated-orcid":false,"given":"Bruno Verri","family":"Jardine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-6345","authenticated-orcid":false,"given":"Priscila Oliveira","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6981-5490","authenticated-orcid":false,"given":"Luiz S\u00e9rgio","family":"Lima-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-2919","authenticated-orcid":false,"given":"Ranieri Andrade","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9778-9746","authenticated-orcid":false,"given":"Ta\u00eds Delazari de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7113-2763","authenticated-orcid":false,"given":"Samuel Luiz Nunes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5010-4914","authenticated-orcid":false,"given":"Ricardo Carvalho","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"1","key":"key20251118212743_B1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study","volume":"21","author":"Wang","year":"2021","unstructured":"Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364. doi: 10.1186\/s12884-021-03809-2","journal-title":"BMC Pregnancy Childbirth"},{"key":"key20251118212743_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145 Suppl 1:1-33. doi: 10.1002\/ijgo.12802","journal-title":"Int J Gynaecol Obstet"},{"key":"key20251118212743_B3","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2022.21","article-title":"Adverse pregnancy and perinatal outcomes in Latin America and the Caribbean: systematic review and meta-analysis","volume":"46","author":"Blanco","year":"2022","unstructured":"Blanco E, Marin M, Nunez L, Retamal E, Ossa X, Woolley KE, et al. Adverse pregnancy and perinatal outcomes in Latin America and the Caribbean: systematic review and meta-analysis. Rev Panam Salud Publica. 2022;46:e21. doi: 10.26633\/RPSP.2022.21","journal-title":"Rev Panam Salud Publica"},{"issue":"9","key":"key20251118212743_B4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0037-1604471","article-title":"Preeclampsia","volume":"39","author":"Ramos","year":"2017","unstructured":"Ramos JG, Sass N, Costa SH. Preeclampsia. Rev Bras Ginecol Obstet. 2017;39(9):496-512. doi: 10.1055\/s-0037-1604471","journal-title":"Rev Bras Ginecol Obstet"},{"key":"key20251118212743_B5","volume-title":"Pr\u00e9-ecl\u00e2mpsia \u2013 Protocolo 2023","author":"Pera\u00e7oli","year":"2023","unstructured":"Pera\u00e7oli JC, Costa ML, Cavalli RC, de Oliveira LG, Korkes HA, Ramos JGL, et al. Pr\u00e9-ecl\u00e2mpsia \u2013 Protocolo 2023. Rede Brasileira de Estudos sobre Hipertens\u00e3o na Gravidez (RBEHG). 2023 [cited 2025 Jan 6]. Available from: https:\/\/rbehg.com.br\/wp-content\/uploads\/2023\/04\/PROTOCOLO-2023.pdf"},{"key":"key20251118212743_B6","volume-title":"Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade. Departamento de Gest\u00e3o do Cuidado Integral. Coordena\u00e7\u00e3o-Geral de Aten\u00e7\u00e3o \u00e0 Sa\u00fade das Mulheres. Coordena\u00e7\u00e3o de Enfrentamento \u00e0 Mortalidade Materna. Departamento de Preven\u00e7\u00e3o e Promo\u00e7\u00e3o da Sa\u00fade. Coordena\u00e7\u00e3o-Geral de Alimenta\u00e7\u00e3o e Nutri\u00e7\u00e3o. Nota T\u00e9cnica Conjunta No. 251\/2024-COEMM\/CGESMU\/DGCI\/SAPS\/MS e CGAN\/DEPPROS\/SAPS\/MS","author":"Brasil","year":"2024","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade. Departamento de Gest\u00e3o do Cuidado Integral. Coordena\u00e7\u00e3o-Geral de Aten\u00e7\u00e3o \u00e0 Sa\u00fade das Mulheres. Coordena\u00e7\u00e3o de Enfrentamento \u00e0 Mortalidade Materna. Departamento de Preven\u00e7\u00e3o e Promo\u00e7\u00e3o da Sa\u00fade. Coordena\u00e7\u00e3o-Geral de Alimenta\u00e7\u00e3o e Nutri\u00e7\u00e3o. Nota T\u00e9cnica Conjunta No. 251\/2024-COEMM\/CGESMU\/DGCI\/SAPS\/MS e CGAN\/DEPPROS\/SAPS\/MS. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2024 [citado 2025 Jan 6]. Dispon\u00edvel em: https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/notas-tecnicas\/2024\/nota-tecnica-conjunta-no-251-2024-coemm-cgesmu-dgci-saps-ms-e-cgan-deppros-saps-ms.pdf\/@@download\/file"},{"key":"key20251118212743_B7","doi-asserted-by":"crossref","DOI":"10.61622\/rbgo\/2024EDT03","article-title":"Prediction and secondary prevention of preeclampsia from the perspective of public health management \u2013 the initiative of the State of Rio de Janeiro","volume":"46","author":"Braga","year":"2024","unstructured":"Braga A, Marinho PS, Nakamura-Pereira M, Pera\u00e7oli JC, Mello C. Prediction and secondary prevention of preeclampsia from the perspective of public health management \u2013 the initiative of the State of Rio de Janeiro. Rev Bras Ginecol Obstet. 2024;46:e-rbgoedt3. doi: 10.61622\/rbgo\/2024EDT03","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"6","key":"key20251118212743_B8","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","unstructured":"Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, et al. Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017;217(6):685.e1-e5. doi: 10.1016\/j.ajog.2017.08.110","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"key20251118212743_B9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613-22. doi: 10.1056\/NEJMoa1704559","journal-title":"N Engl J Med"},{"issue":"2","key":"key20251118212743_B10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0034-89102012005000013","article-title":"The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence","volume":"46","author":"Ben","year":"2012","unstructured":"Ben AJ, Neumann CR, Mengue SS. The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev Sa\u00fade P\u00fablica. 2012;46(2):279-89. doi: 10.1590\/s0034-89102012005000013","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"3","key":"key20251118212743_B11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jclinepi.2009.06.011","article-title":"Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties","volume":"63","author":"Koschack","year":"2010","unstructured":"Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63(3):299-306. doi: 10.1016\/j.jclinepi.2009.06.011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"key20251118212743_B12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/10641955.2010.507851","article-title":"Factors associated with patient understanding of preeclampsia","volume":"31","author":"You","year":"2012","unstructured":"You WB, Wolf M, Bailey SC, Pandit AU, Waite KR, Sobel RM, et al. Factors associated with patient understanding of preeclampsia. Hypertens Pregnancy. 2012;31(3):341-9. doi: 10.3109\/10641955.2010.507851","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"key20251118212743_B13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12884-019-2623-x","article-title":"Knowledge of preeclampsia and its associated factors among pregnant women: a possible link to reduce related adverse outcomes","volume":"19","author":"Fondjo","year":"2019","unstructured":"Fondjo LA, Boamah VE, Fierti A, Gyesi D, Owiredu EW. Knowledge of preeclampsia and its associated factors among pregnant women: a possible link to reduce related adverse outcomes. BMC Pregnancy Childbirth. 2019;19(1):456. doi: 10.1186\/s12884-019-2623-x.","journal-title":"BMC Pregnancy Childbirth"},{"key":"key20251118212743_B14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pcad.2020.08.003","article-title":"Medication adherence: importance, issues and policy: a policy statement from the American Heart Association","volume":"64","author":"Pina","year":"2021","unstructured":"Pina IL, Di Palo KE, Brown MT, Choudhry NK, Cvengros J, Whalen D, et al. Medication adherence: importance, issues and policy: a policy statement from the American Heart Association. Prog Cardiovasc Dis. 2021;64:111-20. doi: 10.1016\/j.pcad.2020.08.003","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"key20251118212743_B15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.preghy.2016.08.232","article-title":"Aspirin adherence during high-risk pregnancies, a questionnaire study","volume":"6","author":"Abheiden","year":"2016","unstructured":"Abheiden CN, van Reuler AV, Fuijkschot WW, de Vries JI, Thijs A, de Boer MA. Aspirin adherence during high-risk pregnancies, a questionnaire study. Pregnancy Hypertens. 2016;6(4):350-5. doi: 10.1016\/j.preghy.2016.08.232","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"key20251118212743_B16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","article-title":"Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study","volume":"75","author":"Shanmugalingam","year":"2020","unstructured":"Shanmugalingam R, Wang X, Motum P, Fulcher I, Lee G, Kumar R, et al. Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study. Hypertension. 2020;75(4):1125-32. doi: 10.1161\/HYPERTENSIONAHA.119.14107","journal-title":"Hypertension"},{"issue":"10220","key":"key20251118212743_B17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","unstructured":"Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285-93. doi: 10.1016\/S0140-6736(19)32973-3","journal-title":"Lancet"},{"key":"key20251118212743_B18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejogrb.2024.10.052","article-title":"The effectiveness of low-dose aspirin for the prevention of hypertensive disorders of pregnancy in a sub-Saharan Africa country: a randomized clinical trial","volume":"303","author":"Mkhize","year":"2024","unstructured":"Mkhize PZ, Dorsamy V, Khaliq OP, Bagwandeen C, Moodley J. The effectiveness of low-dose aspirin for the prevention of hypertensive disorders of pregnancy in a sub-Saharan Africa country: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2024;303:259-65. doi: 10.1016\/j.ejogrb.2024.10.052","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"key20251118212743_B19","doi-asserted-by":"crossref","first-page":"100352","DOI":"10.1016\/j.xagr.2024.100352","article-title":"Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps","volume":"4","author":"Kupka","year":"2024","unstructured":"Kupka E, Roberts JM, Mahdy ZA, Escudero C, Bergman L, De Oliveira L, et al. Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps. AJOG Glob Rep. 2024;4(2):100352. doi: 10.1016\/j.xagr.2024.100352","journal-title":"AJOG Glob Rep"},{"issue":"10","key":"key20251118212743_B20","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"10","author":"Duley","year":"2019","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;10(10):CD004659. doi: 10.1002\/14651858.CD004659.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"key20251118212743_B21","doi-asserted-by":"crossref","first-page":"419.e1","DOI":"10.1016\/j.ajog.2020.03.004","article-title":"Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension","volume":"223","author":"Banala","year":"2020","unstructured":"Banala C, Moreno S, Cruz Y, Boelig RC, Saccone G, Berghella V, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2020;223(3):419.e1-e16. doi: 10.1016\/j.ajog.2020.03.004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"key20251118212743_B22","doi-asserted-by":"crossref","first-page":"251.e1","DOI":"10.1016\/j.ajog.2021.08.004","article-title":"A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China","volume":"226","author":"Lin","year":"2022","unstructured":"Lin L, Huai J, Li B, Zhu Y, Juan J, Zhang M, et al. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2022;226(2):251.e1-e12. doi: 10.1016\/j.ajog.2021.08.004","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"key20251118212743_B23","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","unstructured":"Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217(5):585.e1-e5. doi: 10.1016\/j.ajog.2017.07.038","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"key20251118212743_B24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nyas.14733","article-title":"Calcium supplementation for the prevention of hypertensive disorders of pregnancy: current evidence and programmatic considerations","volume":"1510","author":"Gomes","year":"2022","unstructured":"Gomes F, Ashorn P, Askari S, Belizan JM, Boy E, Cormick G, et al. Calcium supplementation for the prevention of hypertensive disorders of pregnancy: current evidence and programmatic considerations. Ann N Y Acad Sci. 2022;1510(1):52-67. doi: 10.1111\/nyas.14733","journal-title":"Ann N Y Acad Sci"},{"key":"key20251118212743_B25","volume-title":"WHO recommendation: calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO recommendation: calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications. Geneva: World Health Organization; 2018."},{"issue":"3","key":"key20251118212743_B26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.9745\/GHSP-D-20-00008","article-title":"Integrating calcium into antenatal iron-folic acid supplementation in Ethiopia: women's experiences, perceptions of acceptability, and strategies to support calcium supplement adherence","volume":"8","author":"Klemm","year":"2020","unstructured":"Klemm GC, Birhanu Z, Ortolano SE, Kebede Y, Martin SL, Mamo G, et al. Integrating calcium into antenatal iron-folic acid supplementation in Ethiopia: women's experiences, perceptions of acceptability, and strategies to support calcium supplement adherence. Glob Health Sci Pract. 2020;8(3):413-30. doi: 10.9745\/GHSP-D-20-00008","journal-title":"Glob Health Sci Pract"},{"issue":"4","key":"key20251118212743_B27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjms.2016.01.010","article-title":"Medication adherence: truth and consequences","volume":"351","author":"Brown","year":"2016","unstructured":"Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth and consequences. Am J Med Sci. 2016;351(4):387-99. doi: 10.1016\/j.amjms.2016.01.010","journal-title":"Am J Med Sci"},{"issue":"2","key":"key20251118212743_B28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229622","article-title":"Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: a mixed method analysis","volume":"15","author":"Shanmugalingam","year":"2020","unstructured":"Shanmugalingam R, Mengesha Z, Notaras S, Liamputtong P, Fulcher I, Lee G, et al. Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: a mixed method analysis. PLoS One. 2020;15(2):e0229622. doi: 10.1371\/journal.pone.0229622","journal-title":"PLoS One"},{"issue":"5","key":"key20251118212743_B29","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"Olson","year":"2022","unstructured":"Olson DN, Russell T, Ranzini AC. Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence. Am J Obstet Gynecol MFM. 2022;4(5):100663. doi: 10.1016\/j.ajogmf.2022.100663","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:27:53Z","timestamp":1763501273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/low-adherence-to-aspirin-and-calcium-carbonate-for-preeclampsia-prevention-in-pregnant-women-with-chronic-hypertension-in-a-brazilian-hospital\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"alternative-id":["10.61622\/rbgo\/2025rbgo77"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo77","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e-rbgo77"}}